Drug
EG017 clinical trials
Keep track of what changes. Save the EG017 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- EG017
- 1
Studies by the year they started
3 studies that test it; most in 2023 (2)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses EG017 is read from its arms, and is right about nine times in ten.
Testing it · 3
- To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.RecruitingPhase 1Changchun GeneScience Pharmaceutical Co., Ltd.NCT05673694Written as EG017
- A Study for the Treatment of Dry Eye in Postmenopausal WomenRecruitingPhase 2Changchun GeneScience Pharmaceutical Co., Ltd.NCT06133166Written as EG017 ointment
- A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary IncontinenceCompletedPhase 2Changchun GeneScience Pharmaceutical Co., Ltd.NCT05674045Written as EG017 3mg